Treatment of Spontaneous Preterm Birth (2015)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/US2013/077868, filed Dec 26, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,928,402 | Treatment of Spontaneous Preterm Birth In force · High confidence | NX Prenatal Inc. | In force | High confidence | ||
| US 11,835,530 | Detection of Microparticle-Associated Proteins Associated with Spontaneous Preterm Birth In force · High confidence | NX Prenatal Inc. | In force | High confidence | ||
| Application 13/797,933 | Biomarkers of Preterm Birth Abandoned Abandoned May 28, 2019 | NX Prenatal Inc. | Abandoned | Abandoned May 28, 2019 | ||
| Application 18/494,607 | Detection of Microparticle-Associated Proteins Associated with Spontaneous Preterm Birth Pending Not granted | NX Prenatal Inc. | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by NX Prenatal Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.